Pulse Biosciences Schedules Third Quarter 2023 Financial Results Conference Call for November 13, 2023
30.10.2023 - Pulse Biosciences, Inc. (Nasdaq: PLSE, “the Company”), a company primarily focused on leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, today announced it will report ...
Source: wallstreet-online.de